tired on retatrutide is being talked about as the next big weight loss peptide. But a Victorian Government health warning over the weekend has linked products sold as 'Retatrutide' to six cases of acute Most fat-loss plans work… but

The use of GLP-1 receptor agonists not only assists in achieving aesthetic goals but also contributes to metabolic health improvements, such as better blood glucose control and reduced cardiovascular risk factors

Fast Stats

Among those who have taken these drugs, six in ten (62%) say they took them to treat a chronic condition like diabetes or heart disease, including about four in ten (39%) who took them only to treat a chronic condition and one in four (23%) who say they took them to both treat a chronic condition and to lose weight

In addition, fatigue symptoms ranked as the second most common complaint in these online posts despite rarely being reported in clinical trials

"When I look in the mirror I don't see the same person anymore and that's been really hard," she said

Medicare Spending on Ozempic and Other GLP-1s Is Skyrocketing This post was updated on March 27, 2024 to include a clarification of the drugs included in the analysis and additional information about rebates